Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Industry News (Biotechnology)
Market for Monoclonal Antibodies Set to Take-Off
November 20th, 1995
Monoclonal antibodies - antibodies produced in the laboratory by converting the growth mechanism of a tumor into a factory for generating a specific antibody - were developed by two Nobel prize-winning scientists, Georges Kohler and Cesar Milstein, in 1975. Since that time, the use of monoclonal antibodies (MAbs) has grown slowly. Their primary application has been in the diagnosis of various infectious diseases and to treat organ transplant rejection. In 1989, the total MAb market amounted to a relatively meager $61.9 million-$34.3 million from diagnostic applications and $27.6 million from therapeutic use. Between 1989 and 1994, the diagnostics...
Source: Cancer Weekly (1995-11-20)
|
